๐ŸŽ‰ Pharmidex at BMCS SDDD 2025 – Meet Us There!
June 2, 2025

We’re excited to announce that Pharmidex will be exhibiting at the BMCS 5th Synthesis in Drug Discovery and Development Conference, taking place from Tuesday 3rd to Wednesday 4th June 2025


๐Ÿ”— https://lnkd.in/e_GJM8S7


Our Business Development Manager, Janette Dalay Robertson, will be attending and is looking forward to engaging with fellow professionals to foster collaborations and explore how Pharmidex can support your drug discovery and development journey.


Whether you're looking for expertise in in silico, ADME, DMPK, bioanalysis, or neuroscience models, stop by our booth and let’s connect!


๐Ÿ’ฌ Don’t miss the chance to meet Janette Dalay Robertson and discover how Pharmidex promotes scientific excellence through flexible, high-quality preclinical research partnerships.

#Pharmidex #BMCS #SDDD2025 #DrugDiscovery #Exhibitor#PreclinicalResearch #Pharmaceuticals #BusinessDevelopment #Neuroscience #InSilico #DMPK #Bioanalysis #Collaboration

July 17, 2025
We’re growing and looking for passionate scientists to join our dynamic team. If you're excited by impactful science and meaningful collaboration, check out our latest roles: ๐Ÿ”ฌ Bioanalytical Scientist (Permanent) Work with LC-MS/MS platforms to support preclinical and clinical bioanalysis across a wide range of therapeutic areas. ๐Ÿงซ Histology Technician (3-Month FTC, Full or Part-Time) Be at the heart of tissue processing for in vivo and toxicology studies GLP experience welcome, flexibility offered. ๐Ÿงช Scientist / Senior Scientist – Immunology (Full-Time) Advance autoimmune disease research through innovative T-cell and cytokine profiling assays. ๐Ÿ’ก Why Pharmidex? โœ” 20+ years of scientific excellence โœ” Collaborative, science-led culture โœ” Diverse therapeutic expertise โœ” Real-world impact through discovery and development ๐Ÿ“ฉ Ready to apply or want to learn more? Visit www.pharmidex.com/careers or email your CV to [email protected] Applications are reviewed on a rolling basis, early interest encouraged! ๏ปฟ Let’s shape the future of drug discovery together.
July 15, 2025
We’re excited to introduce our GLP-standard intracranial dosing platform delivering targeted compounds directly to the brain for more precise CNS preclinical studies. โœ… Bypasses the blood-brain barrier โœ… Reduces systemic side effects โœ… Enhances translational relevance Now fully GLP-validated with: Documented SOPs & equipment Verified dose placement MHRA-audited compliance ๐Ÿ“ˆ Benefits: Regulatory-ready data, better reproducibility, and lower repeat study costs. ๐Ÿ‘‰ Swipe the carousel to learn more. ๐Ÿ”— www.pharmidex.com
New Insights from Pharmidex: Tumour Microdialysis in Glioblastoma
July 10, 2025
We’re excited to share our latest work on tumour microdialysis, a powerful technique for measuring unbound, pharmacologically active drug concentrations directly within brain tumours like glioblastoma. Unlike systemic plasma levels, microdialysis provides a true picture of drug penetration into the tumour helping to uncover heterogeneous distribution and the impact of the blood-tumour barrier. Our approach involves precise stereotaxic surgery, tumour validation, and sampling from both tumour and healthy brain tissue enabling direct, comparative pharmacokinetic analysis. ๐Ÿ“Š The results? Significant differences in drug exposure between tumour core and surrounding tissue. ๐Ÿ‘‰ Swipe through the carousel to explore our process and findings. ๏ปฟ ๐Ÿ”— www.pharmidex.com
More Posts